Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel R Gomez

Showing results (41-50 of 231) with videos related to

Pageof 24
Sort By:
Cancer Journal (Sudbury, Mass.)|July 22, 2016
Stereotactic Ablative Radiation Therapy Combined With Immunotherapy for Solid TumorsEric D Brooks, Jonathan E Schoenhals, Chad Tang, et al.
Radiation Oncology (London, England)|June 3, 2014
Assessing the robustness of passive scattering proton therapy with regard to local recurrence in stage III non-small cell lung cancer: a secondary analysis of a phase II trialZhengfei Zhu, Wei Liu, Michael Gillin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 9, 2021
Association of prior radiation dose to the cardiopulmonary system with COVID-19 outcomes in patients with cancerQuincey LaPlant, Maria Thor, Narek Shaverdian, et al.
The Journal of Thoracic and Cardiovascular Surgery|April 26, 2020
Pulmonary resection is associated with long-term survival and should remain a therapeutic option in oligometastatic lung cancerKyle G Mitchell, Ahsan Farooqi, Ethan B Ludmir, et al.
Advances in Radiation Oncology|May 8, 2020
Need for Caution in the Diagnosis of Radiation Pneumonitis During the COVID-19 PandemicNarek Shaverdian, Annemarie F Shepherd, Andreas Rimner, et al.
Clinical Lung Cancer|December 3, 2014
Incidental receipt of cardiac medications and survival outcomes among patients with stage III non-small-cell lung cancer after definitive radiotherapyHongmei Wang, Zhongxing Liao, Yan Zhuang, et al.
Translational Oncology|February 12, 2017
The Pulmonary Fibrosis Associated MUC5B Promoter Polymorphism Is Prognostic of the Overall Survival in Patients with Non-Small Cell Lung Cancer (NSCLC) Receiving Definitive RadiotherapyJu Yang, Ting Xu, Daniel R Gomez, et al.
International Journal of Radiation Oncology, Biology, Physics|May 23, 2016
Planning Target Volume D95 and Mean Dose Should Be Considered for Optimal Local Control for Stereotactic Ablative Radiation TherapyLina Zhao, Shouhao Zhou, Peter Balter, et al.
Acta Oncologica (Stockholm, Sweden)|April 9, 2016
Prognosis and predictors of site of first metastasis after definitive radiation therapy for non-small cell lung cancerChad Tang, Zhongxing Liao, Kenneth Hess, et al.
Oncotarget|June 3, 2017
Polymorphisms in BMP2/BMP4, with estimates of mean lung dose, predict radiation pneumonitis among patients receiving definitive radiotherapy for non-small cell lung cancerJu Yang, Ting Xu, Daniel R Gomez, et al.
Pageof 24

Showing results (41-50 of 231) with videos related to

Sort By:
Pageof 24
Cancer Journal (Sudbury, Mass.)|July 22, 2016
Stereotactic Ablative Radiation Therapy Combined With Immunotherapy for Solid TumorsEric D Brooks, Jonathan E Schoenhals, Chad Tang, et al.
Radiation Oncology (London, England)|June 3, 2014
Assessing the robustness of passive scattering proton therapy with regard to local recurrence in stage III non-small cell lung cancer: a secondary analysis of a phase II trialZhengfei Zhu, Wei Liu, Michael Gillin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 9, 2021
Association of prior radiation dose to the cardiopulmonary system with COVID-19 outcomes in patients with cancerQuincey LaPlant, Maria Thor, Narek Shaverdian, et al.
The Journal of Thoracic and Cardiovascular Surgery|April 26, 2020
Pulmonary resection is associated with long-term survival and should remain a therapeutic option in oligometastatic lung cancerKyle G Mitchell, Ahsan Farooqi, Ethan B Ludmir, et al.
Advances in Radiation Oncology|May 8, 2020
Need for Caution in the Diagnosis of Radiation Pneumonitis During the COVID-19 PandemicNarek Shaverdian, Annemarie F Shepherd, Andreas Rimner, et al.
Clinical Lung Cancer|December 3, 2014
Incidental receipt of cardiac medications and survival outcomes among patients with stage III non-small-cell lung cancer after definitive radiotherapyHongmei Wang, Zhongxing Liao, Yan Zhuang, et al.
Translational Oncology|February 12, 2017
The Pulmonary Fibrosis Associated MUC5B Promoter Polymorphism Is Prognostic of the Overall Survival in Patients with Non-Small Cell Lung Cancer (NSCLC) Receiving Definitive RadiotherapyJu Yang, Ting Xu, Daniel R Gomez, et al.
International Journal of Radiation Oncology, Biology, Physics|May 23, 2016
Planning Target Volume D95 and Mean Dose Should Be Considered for Optimal Local Control for Stereotactic Ablative Radiation TherapyLina Zhao, Shouhao Zhou, Peter Balter, et al.
Acta Oncologica (Stockholm, Sweden)|April 9, 2016
Prognosis and predictors of site of first metastasis after definitive radiation therapy for non-small cell lung cancerChad Tang, Zhongxing Liao, Kenneth Hess, et al.
Oncotarget|June 3, 2017
Polymorphisms in BMP2/BMP4, with estimates of mean lung dose, predict radiation pneumonitis among patients receiving definitive radiotherapy for non-small cell lung cancerJu Yang, Ting Xu, Daniel R Gomez, et al.
Pageof 24